Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
19,727,399
-
Share change
-
+1,554,642
-
Total reported value
-
$2,204,560,626
-
Put/Call ratio
-
117%
-
Price per share
-
$111.75
-
Number of holders
-
159
-
Value change
-
+$163,540,605
-
Number of buys
-
89
-
Number of sells
-
57
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q4 2016
As of 31 Dec 2016,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,727,399 shares.
The largest 10 holders included
Capital Research Global Investors, SCOPIA CAPITAL MANAGEMENT LP, PRUDENTIAL PLC, FMR LLC, DEERFIELD MANAGEMENT CO, Viking Global Investors LP, BANK OF AMERICA CORP /DE/, JANUS CAPITAL MANAGEMENT LLC, Capital World Investors, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
159
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.